CVAC Message Board Post 10001188 | CureVac N.V.
home / stock / cvac / cvac message board
rileyd675
(investorshub)
Posted on: Sep/26/2021 11:46:04
Source: investorshub
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=166087173
CureVac is truly a one-stop shop for mRNA
News, Short Squeeze, Breakout and More Instantly...
-
GSK acquires full rights to develop, manufacture and commercialize globally mRNA candidate vaccines for influenza and COVID-19, including combinations CureVac receives €400 million upfront and up to an additional €1.05 billion in development, regulatory and sales milestone pa...
-
Strategic restructuring includes a workforce reduction of approximately 30%, re-focusing on research, development, and innovation to create leaner and more agile organization Prioritization of high-value opportunities in oncology and other selected diseases, leveraging proprietary mRNA tec...
-
Phase 2 study to assess updated formulations for improved immune responses of multivalent vaccine candidate against influenza B strain Study initiated following previously reported interim data from Phase 2 Part of combined Phase 1/2 study in seasonal influenza Composition of vaccine ca...